BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Staging
11 results:

  • 1. The diagnostic role of complete MICM-P in metastatic carcinoma of bone marrow (MCBM) presented with atypical symptoms: A 7-year retrospective study of 45 cases in a single center.
    Wang C; Wang Z; Tong X; Li Y; Liu X; Huang L
    Medicine (Baltimore); 2022 Nov; 101(45):e31731. PubMed ID: 36397369
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Phospho-flow detection of constitutive and cytokine-induced pSTAT3/5, pAKT and pERK expression highlights novel prognostic biomarkers for patients with multiple myeloma.
    Brown R; Yang S; Weatherburn C; Gibson J; Ho PJ; Suen H; Hart D; Joshua D
    Leukemia; 2015 Feb; 29(2):483-90. PubMed ID: 24990616
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
    Bianchi G; Richardson PG; Anderson KC
    J Clin Oncol; 2014 Jul; 32(20):2125-32. PubMed ID: 24888801
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders.
    Harrington A; Olteanu H; Kroft S
    Am J Clin Pathol; 2010 Nov; 134(5):749-61. PubMed ID: 20959658
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
    Patel JL; Shetty S; Salama ME
    Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Detection of micrometastasis of neuroblastoma to bone marrow and tumor dissemination to hematopoietic autografts using flow cytometry and reverse transcriptase-polymerase chain reaction.
    Tsang KS; Li CK; Tsoi WC; Leung Y; Shing MM; Chik KW; Lee V; Ng MH; Yuen P
    Cancer; 2003 Jun; 97(11):2887-97. PubMed ID: 12767104
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Osseous Hodgkin disease.
    Ostrowski ML; Inwards CY; Strickler JG; Witzig TE; Wenger DE; Unni KK
    Cancer; 1999 Mar; 85(5):1166-78. PubMed ID: 10091803
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Anaplastic large-cell lymphoma of null-cell type with multiple bone involvement.
    Suzukawa K; Kojima H; Mori N; Mukai HY; Hori M; Komeno T; Hasegawa Y; Ninomiya H; Nagasawa T
    Ann Hematol; 1998 Dec; 77(6):287-90. PubMed ID: 9875667
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease.
    Filippa DA; Ladanyi M; Wollner N; Straus DJ; O'Brien JP; Portlock C; Gangi M; Sun M
    Blood; 1996 Apr; 87(7):2905-17. PubMed ID: 8639911
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prostate cancer: flow cytometric methods for detection of bone marrow micrometastases.
    Hussain M; Kukuruga M; Biggar S; Sakr W; Cummings G; Ensley J
    Cytometry; 1996 Mar; 26(1):40-6. PubMed ID: 8809479
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Monoclonal antibodies and bronchial cancer].
    Charloux A; Kreisman H; Quoix E; Pauli G
    Bull Cancer; 1994 Sep; 81(9):755-63. PubMed ID: 7703564
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.